Non-invasive Research Approaches to Precision and Personalized Dermatology
Precision Biomarker Platform Technology
DermTech’s platform technology is bringing precision to the practice of dermatology through non-invasive assessment of the skin. Our proprietary technology can be used for biomarker analysis of RNA, DNA, protein, and microbiome.
The Simplicity of the Smart Sticker®
Eliminates need for surgical biopsy and collects 1.5mg of stratum corneum tissue capturing signatures from epidermal keratinocytes, T cells, dendritic cells, melanocytes, etc.1,2,3
Simple Sample Transport
Sample doesn’t require fixation or refrigeration and preserves genomic and proteomic material from the skin for up to 10 days at room temperature & greater than a year when stored at -80°C.
Large Collection Area
Provides 19mm collection area for Lesional and Non-lesional samples.
Precision Biomarker Analysis
Includes Microbiome, Proteomic, NGS, and targeted DNA/RNA analysis.
The Simplicity of the Smart Sticker®
Eliminates need for surgical biopsy and collects 1.5mg of stratum corneum tissue capturing signatures from epidermal keratinocytes, T cells, dendritic cells, melanocytes, etc.1,2,3
Large Collection Area
Provides 19mm collection area for Lesional and Non-lesional samples.
Simple Sample Transport
Sample doesn’t require fixation or refrigeration and preserves genomic and proteomic material from the skin for up to 10 days at room temperature & greater than a year when stored at -80°C.
Precision Biomarker Analysis
Includes Microbiome, Proteomic, NGS, and targeted DNA/RNA analysis.
Your translational medicine partner.
The Smart Sticker offers the opportunity to non-invasively identify biomarkers of disease and subgroups of disease, stratify patients based on genomic and proteomic profiles, enrich for responders in a population, and predict and track responses to therapeutic intervention.
We offer expert services including:
- Biomarker Identification
- New Target Identification
- Patient Segmentation and Stratification
- Bioinformatics Support
DermTech’s validated platform technology is appropriate for indications where skin is the target or a surrogate target organ and is being used to support drug discovery and development programs focused on cancers and inflammatory diseases in clinical research studies.
Research indications include, but are not limited to:
Send us a message
Click the contact us button and drop us a line. We’ll be in touch shortly.
Get In Touch
- Merola et al., (2021). Lupus Science & Medicine
- Markova et al., (2023). Blood (ASH 2023)
- Wachsman et al., (2011). British Journal of Dermatology